WuXi Biologics (WXXWY) Financial Analysis & Valuation | Quarter Chart
WuXi Biologics (WXXWY)
WXXWYPrice: $8.46
Fair Value: 🔒
🔒score
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the bio... more
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, dev... more
Description
Shares
| Market Cap | $17.49B | Exchange | OTC |
| Sector | Healthcare | Industry | Biotechnology |
| Country | CN | CEO | Zhisheng Chen |
| IPO Date | 2017-12-18 | CAGR | 0.46% |
| Employees | 12,575 | Website | www.wuxibiologics.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 3.84% | Total Yield | 3.84% |
WXXWY chart loading...
Fundamentals
Technicals
| Enterprise Value | $105.29B | P/E Ratio | 24.89 |
| Forward P/E | — | PEG Ratio | 0.64 |
| P/S Ratio | 18.63 | P/B Ratio | 8.25 |
| P/CF Ratio | 67.82 | P/FCF Ratio | 228.87 |
| EPS | $0.34 | EPS Growth 1Y | 7.26% |
| EPS Growth 3Y | 368.29% | EPS Growth 5Y | 8395.58% |
| Revenue Growth 1Y | 24.59% | Gross Margin | 0.46% |
| Operating Margin | 0.3% | Profit Margin | 0.23% |
| ROE | 0.11% | ROA | 0.08% |
| ROCE | 0.12% | Current Ratio | 3.14 |
| Quick Ratio | 2.97 | Cash Ratio | 1.11 |
| Debt/Equity | 0.07 | Interest Coverage | 112.45 |
| Altman Z Score | 8.33 | Piotroski Score | 8 |